European Healthcare Investor Association (E.H.I.A.)

US: Investors in Healthcare Networking Drinks at start of J.P. Morgan 43rd Annual Healthcare Conference 📍 Savills, San Francisco 📅 Sunday January 12, 2025 ⏲️ 6.30 pm - 9 pm REGISTER here: https://lnkd.in/e_hMTmYS ** Priority will be given to EHIA member and guests of the sponsors as well as CEOs of European healthcare companies** European Healthcare Investor Association (E.H.I.A.), in association with Marwood Group, and Latham & Watkins, is delighted to be hosting an exclusive drinks reception for European healthcare investors and CEOs to kick off the J.P. Morgan 43rd Annual Healthcare Conference in San Francisco. Hosted in Savills 10th-floor offices with spectacular views from their terrace overlooking Union Square, the evening will provide an excellent opportunity for CEOs and private investors visiting from Europe to network and discuss healthcare investment trends and opportunities with their peers, and US colleagues. #investing #privateequity #healthcare #lifesciences #pharma Heather Pfeiffer Nayan Ghosh Grace Mackintosh Sarah Ward Henry Elphick Robbie McLaren Eveline Van Keymeulen Meloudy O'Reilly Tom Cookson Deniz Tschammler Heather Deixler Dr. Susan Kempe-Müller Olivier du Mottay Neil Campbell Tom Evans Dr. Henning C. Schneider Nick Herbert Savills Operational Capital Markets Austin Barrett Rhys Dumbleton

New Associate Member: Siemens Healthineers pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. As a market leader, they want to advance a world in which breakthroughs in healthcare create new possibilities with a minimal impact on the planet. Siemens Healthineers has been pushing the boundaries in medical technology for more than 125 years. By consistently bringing innovations to the market, they enable healthcare professionals to innovate personalized care, achieve operational excellence, and transform the system of care. With the unique combination of strengths in patient twinning*, precision therapy, as well as digital, data, and artificial intelligence (Al), the company is well positioned to take on the greatest challenges in healthcare. They continue to build on these strengths to help overcome the world's most threatening diseases, enable efficient operations, and expand access to care. Their portfolio, spanning in vitro and in vivo diagnostics to image-guided therapy and cancer care, is crucial for clinical decision-making and treatment pathways. They are committed to improving healthcare access for all, limiting environmental impact as they pioneer breakthroughs, and engaging their diverse Healthineers to achieve this impact on a global scale. Motivated by their purpose and guided by their values, they are building an inclusive culture, where they embrace diversity in all its forms. They are a team of more than 72,000 Healthineers in over 70 countries passionately pushing the boundaries of what is possible in healthcare to help improve the lives of people around the world. *Personalization of diagnosis, therapy selection and monitoring, aftercare, and managing health. Dr. Zoe Kyriakou, Max Grenz, Franziska Koehler, Tobias Alexander Lutz, Jalal Awad, Anna Hochmuth, Luca Regenhardt, Sarah Ward, Henry Elphick, Nick Herbert, Frank Altmeyer #healhtcare #medtech #investing

Switzerland: Recruitment - Investor Member MTIP are looking for an Investment Associate to join their team in Basel. MTIP is a leading Swiss-based growth / buyout firm investing in European healthcare software companies that aim to revolutionise global healthcare. They leverage their deep sector expertise to help scale up successful and sustainable digital health businesses. MTIP are driven by the purpose to empower healthcare software innovation with a potential to transform lives and make a meaningful impact on the world. #recruitment Compass Carter Osborne Christoph Kausch Anja-Vanessa Peter Katrin Vatiska Elizabeth Law Danchen Zhao Anne Mathieu

UK: EHIA Annual Investors in Healthcare Gala Dinner took place last week in London during Jefferies London Healthcare Conference. 180+ guests from 60+ healthcare investors from across the European healthcare investing community enjoyed an excellent evening of networking and fine dining at J.P. Morgan's spectacular Great Hall on Victoria Embankment. A huge thank you to our generous sponsoring partners J.P. Morgan, McKinsey & Company, McDermott Will & Emery and Compass Carter Osborne and to our speakers: ⏩ Alan MacKay Managing Partner and Founder GHO Capital Partners LLP and Chair European Healthcare Investor Association (E.H.I.A.) ⏩ David Quigley Senior Partner Private Capital, Life Science and Healthcare McKinsey & Company ⏩ Sharon Lamb Partner Health and Life Sciences McDermott Will & Emery ⏩ Juha Anjala Co-head EMEA Healthcare and Isik Guven Toktamis EMEA, Head of Financial Sponsors Group from J.P. Morgan If you missed the event, or if you attended but would like to relive it, you can view the photo gallery here https://lnkd.in/e7Bf4n7d #investing #healthcare #privateequity #lifesciences Ting Ting Wang Sayan B. Jamie Littlejohns Sebastian Sieler Ellie West Antonia Grufman Sam L. Luke Osborne David Bland Henry Elphick Sarah Ward Hamid Yunis Alex Bruce James Mitford Klaus H. Hessberger Dr. Akshay Agarwal - MD Ina De Adam Carter

France: European Healthcare Club is meeting next in Paris. 📆 28 November 📍 Le Montana Rooftop 👫 Alexandre Tepas President & CEO BIOBank S.A. and Guillaume Couillard Director GHU Paris psychiatrie & neurosciences #healthcare #privateequity IK Partners Bastien Hermans Astorg

Zero to 5,000+ in less than ten months: Launched only in February, Investors in Healthcare now has over 5,000 followers on LinkedIn. A Google News approved digital business intelligence platform delivering news, data and analysis, we are rapidly becoming the go-to source for high quality relevant insights for investors, and our audience in both highly engaged and international. Our top 10 cities for followers globally reflects this: 1️⃣ London, UK 2️⃣ Paris, France 3️⃣ New York City, US 4️⃣ Milan, Italy 5️⃣ Frankfurt, Germany 6️⃣ Munich, Germany 7️⃣ The Randstad, Netherlands 8️⃣ Zürich, Switzerland 9️⃣ Barcelona, Spain 🔟 Copenhagen, Denmark REGISTER for free to access the latest news here https://lnkd.in/eT5BnYVU or get full access as part of your membership by contacting sarah.ward@ehia.org for login details. #healthcare #lifesciences Nick Herbert Sarah Ward

Video summary of Strategic Partner Knight Frank's recent healthcare property lunch which had two panels looking at the UK and globally and where yields are, what investors are focussed on and where sentiment is heading. 🔴UK Panel - Andrea Auteri (Co-Founders, Elevation), Justin Ash (CEO, Spire Healthcare Group plc), Lisa Attenborough (Head of Debt Advisory, Knight Frank), Pete Calveley (CEO, Barchester Healthcare) and Rebecca Pearson (General Manager, Bupa) 🔴 Global Panel - Justin Hutchens (EVP Ventas, Inc.), Steve Nitschke (MD European Acquisitions Medical Properties Trust, Inc.), Stefaan Gielens (CEO Aedifica NV/SA), Sam Biggins (National Head of Healthcare & Life Sciences, Knight Frank Australia), Sabrina Solomiany (MD, Head of Medical & Life Sciences, Berkadia) and Shehzad Jamal (Partner, Knight Frank MENA) #healthcare #socialcare #realestate Julian Evans Steve Fergus Bhavna Keane Rao BKRCC Kenneth MacKenzie Sir Anthony Ullmann Matthew Lowe William Freston Paul Hammerton Mike Parsons Melissa Magee Nigel Patel John Flannelly Andrew Knight Melissa Jeffery Dr Sanjeev Kanoria Adam Carter Amanda Wright-Kluger

Investor Member Novo Holdings has won the European Lifestars Awards - Celebrating Life Science Leaders 2024 award for Venture Capital Firm.

New Investor Member Inflexion has won Best Pan-European Mid-Market LBO Fund at the 2024 Private Equity Exchange Awards. Achievements highlighted included assets invested in healthcare such as SteriPack Group, Village Vets and European LifeCare Group. #healthcare #lifesciences Bill Colvin B. Com (Edin), C.A. Sarah Gestetner Henry Awit Ravi Shah Robin Senivassen Robert Dagger Christian Fellowes Andrea Johnson  Martin Thrane Pedersen Tushaar Nadkarni Louise Snoy Jackie Phillips Emilie Le Querec

New investor member: Inflexion is a leading European mid-market private equity firm, investing in high growth, entrepreneurial businesses with ambitious management teams and working in partnership with them to accelerate growth. Inflexion’s flexible approach allows it to back both majority and minority investments. With bespoke teams and dedicated capital, Inflexion’s funds invest across a variety of sectors from offices in London, Manchester, Amsterdam, Frankfurt and Stockholm. Inflexion helps businesses achieve the next stage of growth through international expansion, mergers & acquisitions, digital enhancement, commercial strategy, talent management, ESG, and access to Inflexion’s global network. It also benefits from international experts covering Asia and the Americas dedicated to portfolio development, enabling investee companies to benefit from privileged access to these fast-growth markets. Funds advised by Inflexion Private Equity Partners LLP have funds under management of c.£11bn. Inflexion has successfully partnered with 14 businesses across healthcare and life sciences, including Tierarzt Plus Partner (“TPP”), Village Vets, PROTEROS biostructures GmbH, SteriPack Group, Upperton Pharma Solutions, CNX Therapeutics, Rosemont Pharmaceuticals and European LifeCare Group. Andrew Neville, Ravi Shah, Henry Awit, Robin Senivassen, Robert Dagger, Christian Fellowes, Andrea Johnson,  Martin Thrane Pedersen,  Tushaar Nadkarni,  Louise Snoy,  Jackie Phillips, Emilie Le Querec, Sarah Ward, Henry Elphick, Nick Herbert